SCHEMBL6608525

SCHEMBL6608525

CCCN(Cc1ccc(-c2ccccc2-c2nc(=O)o[nH]2)cc1)c1nc2ccccc2cc1C(=O)OCC

nearest known ligand 0.44

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 20/20 0.44
AGTR2 P50052 20/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6610737 0.87 AGTR1 (0.56) AGTR1AGTR2
SCHEMBL6605207 0.85 AGTR1 (0.53) AGTR1AGTR2
SCHEMBL6604855 0.85 AGTR1 (0.43) AGTR1AGTR2
SCHEMBL6608938 0.82 AGTR1 (0.54) AGTR1AGTR2
SCHEMBL8548646 0.82 AGTR1 (0.39) AGTR1AGTR2
SCHEMBL6608915 0.81 AGTR1 (0.42) AGTR1AGTR2
SCHEMBL6606740 0.80 AGTR1 (0.54) AGTR1AGTR2
SCHEMBL8944271 0.79 AGTR2 (0.36) AGTR1AGTR2
SCHEMBL6606977 0.79 AGTR1 (0.67) AGTR1AGTR2
SCHEMBL8944453 0.79 AGTR1 (0.46) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0829479-B1 Heterocyclic compounds and their use as angiotensin II antagonists TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2004-04-14 EP disclosed
EP-0588299-B1 1,2,4-Oxadiazolyl- or 1,2,4-thiadiazolyl-biphenyl derivatives as angiotensin II antagonists TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1998-07-01 EP disclosed
EP-0829479-A1 Heterocyclic compounds and their use as angiotensin II antagonists TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-03-18 EP disclosed
US-5500427-A ANGIOTENSIN II ANTAGONISTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-03-19 US disclosed
EP-0588299-A2 1,2,4-Oxadiazolyl- or 1,2,4-thiadiazolyl-biphenyl derivatives as angiotensin II antagonists TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-03-23 EP disclosed